Bioavailability, Distribution and Pharmacokinetics of Diethylstilbestrol Converted from Diethylstilbestrol Diphosphate in Patients with Prostatic Cancer
Hiroshima Journal of Medical Sciences 35 巻 4 号
325-338 頁
1986-12 発行
アクセス数 : 343 件
ダウンロード数 : 69 件
今月のアクセス数 : 7 件
今月のダウンロード数 : 2 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00049939
ファイル情報(添付) |
HiroshimaJMedSci_35_325.pdf
1.77 MB
種類 :
全文
|
タイトル ( eng ) |
Bioavailability, Distribution and Pharmacokinetics of Diethylstilbestrol Converted from Diethylstilbestrol Diphosphate in Patients with Prostatic Cancer
|
作成者 |
NAKAMURA Koji
|
収録物名 |
Hiroshima Journal of Medical Sciences
|
巻 | 35 |
号 | 4 |
開始ページ | 325 |
終了ページ | 338 |
収録物識別子 |
[PISSN] 0018-2052
[EISSN] 2433-7668
[NCID] AA00664312
|
抄録 |
A method for the radioimmunoassay of diethylstilbestrol (DES) was established to evaluate the distribution of DES in patients with prostatic carcinoma receiving intravenous infusion of 500 mg of diethylstilbestrol diphosphate (DES-DP). The plasma DES concentration was markedly elevated to 4.9 μg/ml immediately after DES-DP infusion and rapidly decreased to 0.8 μg/ml at 3 hr after the DES-DP infusion. The DES concentration in the prostatic tissue was 1.6 μgig w.w. at 1 hr after infusion, and thereafter was predominantly similar to that in the plasma. The DES excretion in the urine was 23.7 mg at 0 to 3 hr after DES-DP infusion, and decreased gradually thereafter. In addition, the DES distribution in the subcellular fractions of benign hypertrophic prostates was studied following DES-DP infusion. The DES concentration in the nuclear fraction decreased with time. Furthermore, the protein specifically bound to DES was not detected in the cytosolic fraction. Therefore, the DES converted from DES-DP did not accumulate in the prostate. Subsequently, the bioavailabilities of DES were examined. The dihydrotestosterone (DHT) content of the prostatic tissue was significantly decreased at 24 hr after DES-DP infusion. However, the cytosolic androgen receptor content was insignificantly changed within 24 hr of infusion. Since the plasma luteinizing hormone (LH) level in the castrated patient with prostatic cancer was significantly lowered 3 hr after infusion, and further decreased with time, the main effect of DES was considered to be suppression of hypophyseal function.
|
著者キーワード |
Diethylstilbestrol
Prostatic cancer
Dihydrotestosterone
Androgen receptor
|
NDC分類 |
医学 [ 490 ]
|
言語 |
英語
|
資源タイプ | 紀要論文 |
出版者 |
Hiroshima University School of Medicine
|
発行日 | 1986-12 |
出版タイプ | Version of Record(出版社版。早期公開を含む) |
アクセス権 | オープンアクセス |
収録物識別子 |
[ISSN] 0018-2052
[NCID] AA00664312
[PMID] 3570844
|